Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

48 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
An interesting fishing expedition.
Quesenberry PJ, Butera JN. Quesenberry PJ, et al. Among authors: butera jn. Cancer Biol Ther. 2009 Feb;8(4):338-9. doi: 10.4161/cbt.8.4.7832. Epub 2009 Feb 12. Cancer Biol Ther. 2009. PMID: 19197147 Free article. No abstract available.
Cellular immunotherapy for refractory hematological malignancies.
Reagan JL, Fast LD, Safran H, Nevola M, Winer ES, Castillo JJ, Butera JN, Quesenberry MI, Young CT, Quesenberry PJ. Reagan JL, et al. Among authors: butera jn. J Transl Med. 2013 Jun 19;11:150. doi: 10.1186/1479-5876-11-150. J Transl Med. 2013. PMID: 23782682 Free PMC article. Clinical Trial.
Nonengraftment donor lymphocyte infusions for refractory acute myeloid leukemia.
Reagan JL, Fast LD, Nevola M, Mantripragada K, Mulder A, Claas FH, Rosati K, Schumacher A, Safran H, Young CT, Quesenberry MI, Winer ES, Butera JN, Quesenberry PJ. Reagan JL, et al. Among authors: butera jn. Blood Cancer J. 2015 Dec 4;5(12):e371. doi: 10.1038/bcj.2015.100. Blood Cancer J. 2015. PMID: 26636286 Free PMC article. Clinical Trial. No abstract available.
Marrow Hypocellularity, But Not Residual Blast Count or Receipt of Reinduction Chemotherapy, Is Prognostic on Day-14 Assessment in Acute Myeloid Leukemia Patients With Morphologic Residual Disease.
Ollila TA, Olszewski AJ, Butera JN, Quesenberry MI, Quesenberry PJ, Reagan JL. Ollila TA, et al. Among authors: butera jn. Clin Lymphoma Myeloma Leuk. 2018 Mar;18(3):204-209. doi: 10.1016/j.clml.2018.01.007. Epub 2018 Jan 31. Clin Lymphoma Myeloma Leuk. 2018. PMID: 29433979
Clonal haematopoiesis of indeterminate potential among cancer survivors exposed to myelotoxic chemotherapy.
Olszewski AJ, Chorzalska AD, Kim AS, Quesenberry PJ, Lopresti ML, Fenton MA, Reagan JL, Butera JN, Sahin I, Hamel C, Robison J, Petersen M, Dubielecka PM. Olszewski AJ, et al. Among authors: butera jn. Br J Haematol. 2019 Aug;186(3):e31-e35. doi: 10.1111/bjh.15861. Epub 2019 Mar 11. Br J Haematol. 2019. PMID: 30859554 Free PMC article. No abstract available.
Transcriptomics of acute myeloid leukaemia core bone marrow biopsies reveals distinct therapy response-specific osteo-mesenchymal profiles.
Treaba DO, Bonal DM, Chorzalska A, Castillo-Martin M, Oakes A, Pardo M, Petersen M, Schorl C, Hopkins K, Melcher D, Zhao TC, Liang O, So EY, Reagan J, Olszewski AJ, Butera J, Anthony DC, Rintels P, Quesenberry P, Dubielecka PM. Treaba DO, et al. Br J Haematol. 2023 Mar;200(6):740-754. doi: 10.1111/bjh.18513. Epub 2022 Nov 10. Br J Haematol. 2023. PMID: 36354085
48 results